Related Experiment Video
Updated: Oct 16, 2025

Author Spotlight: Advancing Immune Monitoring in Critical Care Patients Using Whole Blood Assays
Published on: September 20, 2024
[Erythema multiforme following COVID-19 vaccination (BNT162b2)]
K Wunderlich1,2, T Dirschka3,4
1CentroDerm Klinik Wuppertal, Heinz-Fangman-Str. 57, 42287, Wuppertal, Deutschland. k.wunderlich@centroderm.de.
Abstract:
We report a case of a patient with erythema multiforme major following COVID-19 (coronavirus disease 2019) vaccination. Lesions on skin and mucous membranes developed 48 h after the second dose of the mRNA-vaccine BNT162b2 (Tozinameran, Comirnaty®). Under the application of external glucocorticoids complete resolution was achieved within 3 weeks.
Related Concept Videos
Cross-reactivity
Vaccinations
Allergic Reactions
Allergic Drug Reactions
Myocarditis III: Medical Management
Myocarditis II: Clinical Features and Diagnostic Tests

